Jeffrey Mitchell
Director of Finance/CFO bei LEXAGENE HOLDINGS INC.
Vermögen: 28 076 $ am 31.01.2023
Profil
Jeffrey Mitchell is currently the Chief Financial Officer, Secretary & Treasurer at Lexagene Holdings, Inc. since 2018.
Prior to this, he worked as a Finance Director & Controller at Palomar Medical Technologies LLC.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
LEXAGENE HOLDINGS INC.
0,11% | 19.12.2022 | 152 585 ( 0,11% ) | 28 076 $ | 31.01.2023 |
Aktive Positionen von Jeffrey Mitchell
Unternehmen | Position | Beginn |
---|---|---|
LEXAGENE HOLDINGS INC. | Director of Finance/CFO | 01.03.2018 |
Ehemalige bekannte Positionen von Jeffrey Mitchell
Unternehmen | Position | Ende |
---|---|---|
PALOMAR MEDICAL TECHNOLOGIES INC | Director of Finance/CFO | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
LEXAGENE HOLDINGS INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Palomar Medical Technologies LLC
Palomar Medical Technologies LLC Electronic ComponentsElectronic Technology Palomar Medical Technologies LLC engages in the research, development, manufacturing and distribution of light based systems for cosmetic treatments. The company is involved in developing a differentiated product mix of light-based systems for various treatments through its research and development as well as with its partnerships throughout the world. It is continually developing and testing new indications to further the advancement in light-based treatments. The company operates through two segments: Professional Product and Consumer Product. The Professional Product segment includes all of its light-based products and services for the professional market. The Consumer Product segment includes PaloVia. It offers products based on technologies that include hair removal, body sculpting, including laser-assisted liposuction, removal of vascular lesions such as rosacea, spider veins, port wine stains and hemangiomas, wrinkle reduction, removal of leg veins, removal of benign pigmented lesions such as age and sun spots, freckles and melasma, tattoo removal, acne treatment, skin resurfacing, treatment of red pigmentation in hypertrophic and keloid scars, treatment of verrucae, skin tags, seborrheic keratosis, skin tightening through soft tissue coagulation, removal of scars, including acne scars, stretch marks and warts and soft tissue coagulation. Palomar Medical Technologies was founded in 1987 and is headquartered in Burlington, MA. | Electronic Technology |